Drug Profile
Constipation therapeutic - Nordic Life Science Pipeline
Alternative Names: TransilonLatest Information Update: 14 Sep 2023
Price :
$50
*
At a glance
- Originator Nordic life science pipeline
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Constipation
Most Recent Events
- 14 Sep 2023 Constipation therapeutic is still in preclinical trials for Constipation in Canada (Unspecified route) (Nordic life science pipeline, September 2023)
- 05 Aug 2016 Preclinical development is ongoing in Canada
- 30 May 2014 Preclinical trials in Constipation in Canada (unspecified route)